OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
Huiping Shuai, Jasper Fuk‐Woo Chan, Bingjie Hu, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 693-699
Open Access | Times Cited: 618
Huiping Shuai, Jasper Fuk‐Woo Chan, Bingjie Hu, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 693-699
Open Access | Times Cited: 618
Showing 1-25 of 618 citing articles:
SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 989
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 989
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Bo Meng, Adam Abdullahi, Isabella A. T. M. Ferreira, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 706-714
Open Access | Times Cited: 977
Bo Meng, Adam Abdullahi, Isabella A. T. M. Ferreira, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 706-714
Open Access | Times Cited: 977
The evolution of SARS-CoV-2
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 791
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 791
SARS-CoV-2 Omicron variant: recent progress and future perspectives
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 479
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 479
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
Daichi Yamasoba, Izumi Kimura, Hesham Nasser, et al.
Cell (2022) Vol. 185, Iss. 12, pp. 2103-2115.e19
Open Access | Times Cited: 313
Daichi Yamasoba, Izumi Kimura, Hesham Nasser, et al.
Cell (2022) Vol. 185, Iss. 12, pp. 2103-2115.e19
Open Access | Times Cited: 313
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 282
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 282
The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein
Thomas P. Peacock, Jonathan C. Brown, Jie Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 255
Thomas P. Peacock, Jonathan C. Brown, Jie Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 255
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
Ryuta Uraki, Maki Kiso, Shun Iida, et al.
Nature (2022) Vol. 607, Iss. 7917, pp. 119-127
Open Access | Times Cited: 255
Ryuta Uraki, Maki Kiso, Shun Iida, et al.
Nature (2022) Vol. 607, Iss. 7917, pp. 119-127
Open Access | Times Cited: 255
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
Panke Qu, John P. Evans, Julia N. Faraone, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 1, pp. 9-17.e3
Open Access | Times Cited: 245
Panke Qu, John P. Evans, Julia N. Faraone, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 1, pp. 9-17.e3
Open Access | Times Cited: 245
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 167-167
Open Access | Times Cited: 205
Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 167-167
Open Access | Times Cited: 205
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Rahul K. Suryawanshi, Irene P. Chen, Tongcui Ma, et al.
Nature (2022) Vol. 607, Iss. 7918, pp. 351-355
Open Access | Times Cited: 181
Rahul K. Suryawanshi, Irene P. Chen, Tongcui Ma, et al.
Nature (2022) Vol. 607, Iss. 7918, pp. 351-355
Open Access | Times Cited: 181
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
Peter Bager, Jan Wohlfahrt, Samir Bhatt, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 7, pp. 967-976
Open Access | Times Cited: 180
Peter Bager, Jan Wohlfahrt, Samir Bhatt, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 7, pp. 967-976
Open Access | Times Cited: 180
Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis
Yang Pan, Liang Wang, Zhaomin Feng, et al.
The Lancet (2023) Vol. 401, Iss. 10377, pp. 664-672
Open Access | Times Cited: 173
Yang Pan, Liang Wang, Zhaomin Feng, et al.
The Lancet (2023) Vol. 401, Iss. 10377, pp. 664-672
Open Access | Times Cited: 173
Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters
Shuofeng Yuan, Zi‐Wei Ye, Ronghui Liang, et al.
Science (2022) Vol. 377, Iss. 6604, pp. 428-433
Closed Access | Times Cited: 168
Shuofeng Yuan, Zi‐Wei Ye, Ronghui Liang, et al.
Science (2022) Vol. 377, Iss. 6604, pp. 428-433
Closed Access | Times Cited: 168
Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters
Katherine McMahan, Victoria Giffin, Lisa H. Tostanoski, et al.
Med (2022) Vol. 3, Iss. 4, pp. 262-268.e4
Open Access | Times Cited: 159
Katherine McMahan, Victoria Giffin, Lisa H. Tostanoski, et al.
Med (2022) Vol. 3, Iss. 4, pp. 262-268.e4
Open Access | Times Cited: 159
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice
Suzanne M. Scheaffer, Diana Lee, Bradley Whitener, et al.
Nature Medicine (2022) Vol. 29, Iss. 1, pp. 247-257
Open Access | Times Cited: 152
Suzanne M. Scheaffer, Diana Lee, Bradley Whitener, et al.
Nature Medicine (2022) Vol. 29, Iss. 1, pp. 247-257
Open Access | Times Cited: 152
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants
Panke Qu, Julia N. Faraone, John P. Evans, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112443-112443
Open Access | Times Cited: 152
Panke Qu, Julia N. Faraone, John P. Evans, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112443-112443
Open Access | Times Cited: 152
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Alexander Wilhelm, Marek Widera, Katharina Grikscheit, et al.
EBioMedicine (2022) Vol. 82, pp. 104158-104158
Open Access | Times Cited: 148
Alexander Wilhelm, Marek Widera, Katharina Grikscheit, et al.
EBioMedicine (2022) Vol. 82, pp. 104158-104158
Open Access | Times Cited: 148
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
Jun Zhang, Yongfei Cai, Christy L. Lavine, et al.
Cell Reports (2022) Vol. 39, Iss. 4, pp. 110729-110729
Open Access | Times Cited: 142
Jun Zhang, Yongfei Cai, Christy L. Lavine, et al.
Cell Reports (2022) Vol. 39, Iss. 4, pp. 110729-110729
Open Access | Times Cited: 142
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, et al.
EBioMedicine (2022) Vol. 84, pp. 104270-104270
Open Access | Times Cited: 140
Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, et al.
EBioMedicine (2022) Vol. 84, pp. 104270-104270
Open Access | Times Cited: 140
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 116
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 116
Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants
Panke Qu, Kai Xu, Julia N. Faraone, et al.
Cell (2024) Vol. 187, Iss. 3, pp. 585-595.e6
Open Access | Times Cited: 105
Panke Qu, Kai Xu, Julia N. Faraone, et al.
Cell (2024) Vol. 187, Iss. 3, pp. 585-595.e6
Open Access | Times Cited: 105
Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models
Lena Mautner, Mona Hoyos, Alexandra Dangel, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 99
Lena Mautner, Mona Hoyos, Alexandra Dangel, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 99
Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation
Da‐Yuan Chen, Chue Vin Chin, Devin Kenney, et al.
Nature (2023) Vol. 615, Iss. 7950, pp. 143-150
Open Access | Times Cited: 99
Da‐Yuan Chen, Chue Vin Chin, Devin Kenney, et al.
Nature (2023) Vol. 615, Iss. 7950, pp. 143-150
Open Access | Times Cited: 99
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 96
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 96
